Upload
others
View
18
Download
0
Embed Size (px)
Citation preview
Childhood Immunisation: Achievements and Challenges
Helen BedfordCentre for Paediatric Epidemiology and BiostatisticsUCL Institute of Child Health, London
London 13th June 2011 GAVI alliance – Pledging conference for immunisation
"vaccines are magic“ Bill Gates, Co- Chair, Bill & Melinda Gates Foundation
"...If ……. we reach or exceed GAVI’s target of $3.7 billion over the next five years…we will protect at least a quarter of a billion children against killer diseases and save 4 million lives " David Cameron
Edward Jenner 1749-1823
Childhood immunisation
• Highly effective intervention • ‘The two public health interventions that have had
the greatest impact on the world’s health are clean water and vaccines’ WHO
• Data from the USA show the 2-dose measles, mumps and rubella vaccination programme saves $3.5 billion for direct costs and $7.6 billion for societal costs
Immunisation is the safest way to protect your baby from very serious diseases such as measles, meningitis, whooping cough and polio.
Measles-2011
• Eliminated from:– Finland 1996– USA 2000– Australia 2008– Significant declines in
Africa-“….measles has now become so uncommon that some younger West African doctors have never seen a single case” (de Groot 2008)
Gillray 1802
1853-British Vaccination Act
• vaccination compulsory for all infants in first 3 months of life
• monetary penalties or imprisonment
• anti-(compulsory) vaccination movement
• opponents to government intrusion on personal autonomy
• 1890s allowed conscientious objection-increased vaccine uptake
• repealed in 1948
Public concerns about vaccines
Multiple sclerosis & Hepatitis vaccineMercury in vaccines & neurological damage
M Multiple vaccines & immune dysfunction
Whole cell pertussis vaccine and neurological damageMMR vaccine & autism and bowel disease
Public concerns about vaccines
–– Tetanus vaccine contaminated with contraceptives
Polio vaccine contaminated with HIV/contraceptives
0
20
40
60
80
100
120
140
160
180
200
1940 1950 1960 1970 1980 1990 2000
Year
Notifi
catio
ns (t
hous
ands
) Vaccine uptake (%)
Whooping cough cases and vaccine coverage England and Wales 1940-2008
Immunisationintroduced
0
100
50
Source: OPCS/DH
Prepared by: CDSC
Case series of 12 children •suspected autism/ autistic spectrum•In 8 onset of symptoms after MMR vaccine•“ We did not prove an association between measles, mumps and rubella vaccine and the syndrome described.”
•“There is sufficient concern in my own mind for a case to be made for vaccines to be given individually at not less than one year intervals.” (A.Wakefield- press conference)
MMR autism and bowel disease
MMR vaccine-autism and bowel disease• 1998-2011-over 13 robust epidemiological studies
– Shifting hypothesis
• Evidence of no link between MMR vaccine autism and bowel disease
• Original ‘research’ discredited and Lancet paper retracted
• Lead author struck off medical register
British Medical Journal-Jan 2011
• Three part series in which investigative journalist Brian Deer provides evidence that ‘MMR scare’ was a fraud.
• No single case of the 12 reported in 1998 paper can be reconciled with the medical records-i.e. facts altered to provide the results wanted.
Measles confirmed cases England and Wales 1996-2011
0
200
400
600
800
1000
1200
1400
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010*
2011**
2010* (provisional data), 2011** (first quarter)
Source: Health Protection Agency 2011
UK Childhood Vaccination Schedule-2011• Vaccines offered routinely mainly in first two years of life
diphtheria, tetanus, polio, pertussis (whooping cough),Haemophilus influenzae type b (five-in-one) meningococcal C, pneumococcal, measles, mumps and rubellaHuman Papilloma Virus vaccine (HPV)-girls only
• Vaccines offered selectivelyBCGhepatitis Binfluenza
• Vaccines being considered by Joint Committee on vaccination and Immunisation (JCVI)
Universal hepatitis BVaricellaRotavirusMeningococcal b
Vaccine Uptake-England 2009-10
12 months of age– 94% DTaP/IPV/Hib x 3
24 months of age– 88% MMR
5 years of age– 85% Pre school booster– 83% MMR x 2
PCT range81%-98%
73%-95%
58%-94%
58%-92%
Source: NHS Information Centre 2011
Immunisation uptake in UK Millennium Cohort Study
• 18,819 children born in the four UK countries 2000-2002
• Interviewed in home-detailed socio-demographic information gathered. Mothers reported their children’s vaccine status
– 9 months-primary vaccine uptake & reasons if not complete (n=18,488)
– 3 years-MMR uptake & reasons if no MMR (n=14,578)
Samad et al. BMJ 2006 332:1312-3 Samad et al Vaccine. 2006; 24:6823-9Pearce et al., BMJ 2008;336:754-7
What do we know about parents whose children are not fully immunised?
• Children unimmunised-(1%) parents usually made active decision-”active rejectors”– Older mothers, more highly educated mothers
• Children with incomplete immunisations-(3%) often access to services is issue-”passive defaulters”– Younger mothers, lone parents, larger families, baby had a least
one hospital admission
Mothers’ reasons for partial and no primary immunisation n=18,488
Mothers’ reasons
Unimmunisedn=228
1%
Partially immunisedn=697 3%
TotalN=925
Beliefs and attitudes
47% (92) 12% (57) 16% (149)
Practical/ accessibility
12% (29) 32% (235) 28% (264)
Medical 33% (84) 45% (328) 44% (412)
Other 8% (23) 11% (77) 10% (100)
Mothers’ reasons for partial and no primary immunisation
• Beliefs and attitudes– “I’ve read up about it and I just don’t like the side effects
and the ingredients in them”
• Accessibility issues – “. . ..transport problems due to having two small children.
. .the surgery is quite far away and they only do the surgery on Wednesdays and I can’t get from the nursery to the surgery easily”
Approaches for parents with accessibility/practical difficulties
• Enhancing access to vaccination services– timing of immunisation sessions– location of immunisation sessions– child and family friendly setting– opportunistic immunisation
• children’s centres• extended schools• GP surgeries• domiciliary• hospitals
Approaches for parents who actively decline immunisation
• May be little that can be done for this group• Repeated reminders may be of little value• Opportunity to discuss concerns and questions with
well informed health professional/s• Provision of more and more information not
necessarily the answer • Information needs to be tailored to respond to
individual’s concerns• Nature of communication is critical• TRUST is pivotal
Approaches for parents who have concerns and questions re immunisation• ?20-30% parents in USA and European countries
accept vaccines while having concerns and questions about vaccines
• Such parents could change their minds about accepting vaccines
• Questions and concerns to be encouraged• Listen to concerns• Build and sustain trust with this group-immunise
them against more extreme views
Internet and social media
• Parents seeking information search the Internet• “University of Google”• Evidence based sound material alongside
anecdote, personal opinion and misinformation• Social media-”Facebook” and “Twitter”-building of
virtual communities-quick to pick up and amplify concerns from other countries
• We have been slower to engage in these forms of communication
The power of the Internet
• Scullard et al 2010. Looked for advice via Google for 5 common paediatric problems-35% of websites searched gave incorrect information re MMR and autism.
• Betsch et al 2010. Viewing vaccine critical material for 5-10 minutes significantly increased perception of vaccine risk and reduced perception of risk of not having vaccine
Should UK resort to the law?
– Few countries have compulsory vaccination– US requirement for children to be immunised before
entering school– States vary in enforcement – exemptions on religious and philosophical grounds– In UK is we have achieved high uptake without need
to legislate-potential to make more parents reject– Maybe a case for excluding unimmunised children
from school in event of an outbreak
Conclusions• Vaccines highly effective• Accessibility remains an issue for some parents• Real challenge is ensuring we develop a better
understanding of public concerns about vaccines• Demand rigorous evidence of safety, efficacy,
technical issues re vaccines• Same level of evidence required re public’s
attitudes and for effective communication strategies
• Build and sustain trust with the public